Xarelto is a blood thinner developed to replace Coumadin, which has been around since the 1950s. Blood thinners are used to help people that have suffered clotting in the past to thin the blood and decrease the risk of future clotting events. In May 2014, the Institute for Safe Medication Practices reported an increase in serious adverse events in individuals taking Xarelto. The adverse events were bleeding events such as gastrointestinal bleeds and hemorrhagic strokes. This concern led to the investigations to determine whether or not there were grounds for Xarelto lawsuits for those who suffered from these conditions. Buchanan, Williams & O’ Brien is evaluating cases for individuals, or family members of individuals, that have suffered serious bleeding events, including hemorrhagic strokes and gastrointestinal bleeds, while taking Xarelto. BWO works with the St. Louis law firm of Niemeyer, Grebel & Kruse, LLC (NGK) to handle these cases. The NGK law firm has extensive experience handling lawsuits involving blood thinners such as Xarelto. NGK was appointed lead counsel for consolidated lawsuits involving Pradaxa, which is a blood thinner that had similar bleeding complications as Xarelto. The NGK law firm has already filed a Xarelto lawsuit. The lawsuit alleges that the makers of Xarelto sold the drug claiming that individuals do not need to submit to monthly blood tests to ensure proper dosage, which is required for patients taking Coumadin. The makers marketed Xarelto as a more convenient alternative Coumadin. The lawsuit alleges that individuals on Xarelto do, in fact, need to regularly monitor their blood levels because the lack of monitoring leads to an increase in the risk of bleeding events such as:
Strokes and brain hemorrhages
Fatal injuries caused by bleeding that cannot be stopped
Bleeding in the intestines
If you or a family member has suffered a hemorrhagic stroke or gastrointestinal bleed while taking Xarelto, contact BWO today. We will meet with you free of charge to evaluate your case.